Detection and treatment of subclinical tuberculosis

Brian D. Robertson, Danny Altmann, Clif Barry, Bill Bishai, Stewart Cole, Dick Thomas Dick, Ken Duncan, Chris Dye, Sabine Ehrt, Hanif Esmail, Joanne Flynn, Richard Hafner, Gray Handley, Willem Hanekom, Paul Van Helden, Gilla Kaplan, Stefan H.E. Kaufmann, Peter Kim, Christian Lienhardt, Valerie MizrahiEric Rubin, Dirk Schnappinger, David Sherman, Jelle Thole, Omar Vandal, Gerhard Walzl, Digby Warner, Robert Wilkinson, Douglas Young

Research output: Contribution to journalComment/debatepeer-review

29 Scopus citations


Reduction of active disease by preventive therapy has the potential to make an important contribution towards the goal of tuberculosis (TB) elimination. This report summarises discussions amongst a Working Group convened to consider areas of research that will be important in optimising the design and delivery of preventative therapies. The Working Group met in Cape Town on 26th February 2012, following presentation of results from the GC11 Grand Challenges in Global Health project to discover drugs for latent TB.

Original languageEnglish (US)
Pages (from-to)447-452
Number of pages6
Issue number6
StatePublished - Nov 2012
Externally publishedYes


  • Detection
  • Subclinical
  • Treatment
  • Tuberculosis

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Detection and treatment of subclinical tuberculosis'. Together they form a unique fingerprint.

Cite this